Detailed, evidence-based help for common painful problems

First drug for chronic migraine prevention 

 •  • by Paul Ingraham
Weekly nuggets of pain science news and insight, usually 100-300 words, with the occasional longer post. The blog is the “director’s commentary” on the core content of PainScience.com: a library of major articles and books about common painful problems and popular treatments. See the blog archives or updates for the whole site.

First drug for chronic migraine prevention just approved by EU; it got a greenlight from the FDA in May. It's kind of amazing that this is the first drug specifically for migraine prevention ("we can put a man on the moon …") but better late than never? Some good quality analysis here:

Aimovig’s performance relative to a placebo treatment is not that great; it’s not even twice as effective as placebo … But in the clinic, outside of the rarefied circles of clinical trials, clinicians are excited.

End of post marker

Last post: “The heel strikes back”

Next post: Your money, your life: how Google ranks webpages that matter